Retina Synthesis

147 Avsnitt

1. 18 Month Results of the Derby and Oaks Trials for Treatment of Geographic Atrophy

   Publicerades: 2022-08-04
2. A Novel Retinal Sealant

   Publicerades: 2022-07-28
3. New Developments in Imaging and Therapy of Sickle Cell Retinopathy

   Publicerades: 2022-07-21
4. High Dose (8mg) Aflibercept for Treatment of Neovascular AMD

   Publicerades: 2022-07-07
5. New Developments in the Management of Choroidal Melanoma

   Publicerades: 2022-06-30
6. A Stem Cell Implant for the Treatment of Geographic Atrophy

   Publicerades: 2022-06-23
7. DERBY and OAKS Results

   Publicerades: 2022-06-16
8. Artificial Intelligence in the Management of Macular Degeneration

   Publicerades: 2022-06-09
9. An Oral Agent for the Treatment of Diabetic Retinopathy

   Publicerades: 2022-06-02
10. Home OCT Monitoring of Neovascular AMD Treatment

    Publicerades: 2022-05-26
11. Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies

    Publicerades: 2022-05-19
12. The Kingfisher Trial of Brolucizumab for DME

    Publicerades: 2022-05-12
13. Subretinal Fluid in Neovascular AMD: Friend or Foe?

    Publicerades: 2022-05-05
14. Optogenetics

    Publicerades: 2022-04-28
15. Inhibition of Plasma Kallikrein in Diabetic Macular Edema

    Publicerades: 2022-04-21
16. Neovascular AMD: Unpacking Surgical Disease Management Options

    Publicerades: 2022-04-14
17. Ocular Therapeutics Sustained Release TKI Trial

    Publicerades: 2022-04-07
18. Gene Therapy of nAMD and Diabetic Retinopathy with Dr. Allen Ho

    Publicerades: 2022-03-31
19. Long Term Results of the Port Delivery System

    Publicerades: 2022-03-24
20. The Altissimo Study using a TKI for nAMD

    Publicerades: 2022-03-17